THBD and COVID-19: The observed trend of increased mortality in conjunction with elevated levels of thrombomodulin and d-Dimer on day 5 may be attributable to disease progression, occurrence of micro-thrombosis in intervening period, increasing systemic inflammation due to COVID-19 or secondary infections.